Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01904123
What this trial is testing

STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaRecurrent Brain Neoplasm+2 more
M.D. Anderson Cancer Center 8
Not applicableNot Yet RecruitingNCT06780397
What this trial is testing

Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients

Who this might be right for
Melanoma, Stage IIMelanoma Stage IIIMelanoma Stage IV
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableUnknownNCT01878396
What this trial is testing

Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors

Who this might be right for
Metastatic Melanoma
Istituto Oncologico Veneto IRCCS 200
Testing effectiveness (Phase 2)Study completedNCT00022464
What this trial is testing

CCI-779 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT01363206
What this trial is testing

Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma

Who this might be right for
Malignant Melanoma, Metastatic
Lynn E. Spitler, MD 29
Testing effectiveness (Phase 2)Study completedNCT00609011
What this trial is testing

Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Myrexis Inc. 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619898
What this trial is testing

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

Who this might be right for
ColitisHepatitisMelanoma (Skin Cancer)
Therakos LLC 112
Not applicableStudy completedNCT02700971
What this trial is testing

RATIO: Rational Approach To Immuno-Oncology

Who this might be right for
Metastatic Melanoma
AHS Cancer Control Alberta 35
Testing effectiveness (Phase 2)Study completedNCT00513604
What this trial is testing

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental+1 more
National Cancer Institute (NCI) 158
Testing effectiveness (Phase 2)Study completedNCT00861913
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT02493361
What this trial is testing

Trial of pIL-12/MK-3475 in Metastatic Melanoma

Who this might be right for
Melanoma
University of California, San Francisco 24
Early research (Phase 1)Study completedNCT03875079
What this trial is testing

Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Hoffmann-La Roche 83
Testing effectiveness (Phase 2)UnknownNCT03913923
What this trial is testing

Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
MelanomaMelanoma Metastatic
Biocad 117
Testing effectiveness (Phase 2)UnknownNCT03095079
What this trial is testing

Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 70
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Study completedNCT00002860
What this trial is testing

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 77
Testing effectiveness (Phase 2)Study completedNCT00626860
What this trial is testing

The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma

Who this might be right for
Metastatic Melanoma
Beth Israel Deaconess Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01835145
What this trial is testing

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Uveal MelanomaStage III Uveal Melanoma AJCC v7Stage IIIA Uveal Melanoma AJCC v7+3 more
National Cancer Institute (NCI) 47
Not applicableStudy completedNCT03879395
What this trial is testing

Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study

Who this might be right for
Melanoma Stage IvMelanoma MetastaticAbdominal Tumor
Vastra Gotaland Region 15
Early research (Phase 1)Study completedNCT04109456
What this trial is testing

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
InxMed (Shanghai) Co., Ltd. 51
Next Page